Manvi Biopharma Private Limited

Manvi Biopharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2018PTC127913 Incorporated 26 October 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma Startup India MSME · Small
Revenue · FY 2021
₹13.05 Cr
▲ 252.16% YoY
Net loss · FY 2021
₹65.47 Lakh
Net margin -5%
EBITDA · FY 2021
₹1.58 Cr
EBITDA margin 12.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹33.33 Lakh
Issued & subscribed
Open charges
₹12.8 Lakh
Satisfied ₹3.4 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
13
Provident fund records

About Manvi Biopharma Private Limited

Data last updated:

Manvi Biopharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 October 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC127913. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.33 Lakh. It is led by directors including Gnana Supriya Gandavarapu and Ramakanth Katta.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No.186/B I.D.A. Mallapur, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2021, the company reported a revenue of ₹13.05 Cr. For the same year it recorded a net loss of ₹65.47 Lakh (net margin -5%) and EBITDA of ₹1.58 Cr (EBITDA margin 12.1%).

The company has about 13 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Manvi Biopharma. As per MCA filings, the company has open charges of ₹12.8 Lakh and satisfied charges of ₹3.4 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 3 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5.5 Cr; the latest was in November 2020.

Manvi Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0011339). For more details, the company can be reached via its website manvibiopharma.com.

Company details

CIN U74999TG2018PTC127913
Registration Number 127913
Incorporation Date 26 October 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-TS-02-0011339

Recognitions & Rankings of Manvi Biopharma

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0011339

Contact details

Manvi Biopharma Private Limited's registered office is in Hyderabad, Telangana. Its website is manvibiopharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.186/B I.D.A. Mallapur, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, Pharma Contract R&D, API Manufacturers

To see the full contact details of Manvi Biopharma Private Limited, buy the company report.

Comprehensive company report
Manvi Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Manvi Biopharma operates one associated brand: Manvi Biopharma. Each brand links to its own profile.

BrandDescriptionWebsite
Offers contract research and manufacturing of API intermediates and chemicals.manvibiopharma.com

Financials of Manvi Biopharma Private Limited

FY 2021 filings available

Manvi Biopharma Private Limited reported revenue of ₹13.05 Cr for FY 2021.

Revenue · FY 2021
₹13.05 Cr
Net loss · FY 2021
₹65.47 Lakh margin -5%
EBITDA · FY 2021
₹1.58 Cr margin 12.1%

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹13.05 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.58 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹65.47 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin12.1%
Net Profit Margin-5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Manvi Biopharma Private Limited, buy the company report.

Board of directors of Manvi Biopharma Private Limited

Manvi Biopharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gnana Supriya GandavarapuDirector20 Feb 20206 Years 8 MonthsCurrent
Ramakanth KattaDirector21 Dec 20205 Years 10 MonthsCurrent
Varunkumarreddy KoduruDirector10 May 20197 Years 6 MonthsCurrent
Nagamani KaperlaDirector26 Oct 20188 Years 0 MonthsCurrent

Auditor

Manvi Biopharma Private Limited is audited by K P & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
K P & ASSOCIATESFY 2021012191S

Shareholding

The shareholding of Manvi Biopharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Manvi Biopharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12.8 Lakh
Satisfied charges
₹3.4 Cr
Breakdown by lending institutions
The South Indian Bank Limited₹0.13 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Mar 2020100349655The South Indian Bank Limited₹12.8 LakhOpen
27 Dec 2019100324763The South Indian Bank Limited₹3.4 CrSatisfied

To see the full charge records of Manvi Biopharma Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Manvi Biopharma Private Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5.5 Cr; the latest was in November 2020.

Total deals
4
Secondary share transfers
2
Rights issue
1
Funding round
1
Disclosed funding
₹5.5 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Nov 2020Funding round₹5.5 CrInvestors: 2 individuals
Dec 2019Rights issue₹29 LakhInvestors: 4 individuals
Oct 2019Secondary share transferUndisclosedBuyer: an individual
Seller: 3 individuals
Apr 2019Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Manvi Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Manvi Biopharma Private Limited has a workforce of 13 employees on its EPFO records as of Jul 2025, across 1 active EPFO establishment.

Employee count
13
Active EPFO establishments
1
Employee growth
-13.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-2613
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Manvi Biopharma Private Limited, buy the company report.

GST

Manvi Biopharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Manvi Biopharma Private Limited, buy the company report.

Recent activity

Manvi Biopharma Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Midhunbabu Reddy Gandavarapu ceased to be Director on 09 Jan 2023.

Ceased
Midhunbabu Reddy Gandavarapu ceased to be Director.
AGM
Manvi Biopharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Charges
A charge registered on 27 Dec 2019 via Charge ID 100324763 with The South Indian Bank Limited was fully satisfied on 09 Sep 2021.
Filing
Manvi Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Appointed
Ramakanth Katta was appointed as Director.
Ceased
Vijaya Laxmi Bangaru ceased to be Director.
Charges
A charge with The South Indian Bank Limited of Rs. 340.00 Lakh registered on 27 Dec 2019 with Charge ID 100324763 was modified on 08 Jun 2020.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 12.80 Lakh with Charge ID 100349655 was registered on 06 Mar 2020.
Appointed
Gnana Supriya Gandavarapu was appointed as Director.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 340.00 Lakh with Charge ID 100324763 was registered on 27 Dec 2019.
Appointed
Varunkumarreddy Koduru was appointed as Director.
Appointed
Nagamani Kaperla was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Manvi Biopharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 October 2018 (8+ years old) and is registered under CIN U74999TG2018PTC127913.

Manvi Biopharma has 4 current directors:

The latest financial statements of Manvi Biopharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.

No. Manvi Biopharma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Manvi Biopharma is U74999TG2018PTC127913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Manvi Biopharma has 4 court cases on record: 4 filed against it. 3 are pending.

Manvi Biopharma was incorporated on 26 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

Manvi Biopharma has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹5.5 Cr; the latest was in November 2020.

Midhunbabu Reddy Gandavarapu ceased to be Director on 09 Jan 2023. Ramakanth Katta was appointed as Director on 21 Dec 2020. Vijaya Laxmi Bangaru ceased to be Director on 15 Jul 2020. Manvi Biopharma has 6 board changes on record in total.

Yes, Manvi Biopharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).